Juniper Pharm Inc (JNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 11,247 | 20,930 | 11,556 | 11,610 | 10,477 |
| Cost of Goods | 6,556 | 5,771 | 5,705 | 6,467 | 6,350 |
| Gross Profit | 4,691 | 15,159 | 5,851 | 5,143 | 4,127 |
| Operating Expenses | 6,702 | 6,813 | 6,379 | 7,887 | 6,215 |
| Operating Income | -1,455 | 9,117 | 177 | -2,277 | -1,738 |
| Interest Expense | 28 | 23 | 24 | 24 | 26 |
| Other Income | 42 | 564 | 90 | 81 | 125 |
| Pre-tax Income | -1,441 | 9,658 | 243 | -2,220 | -1,639 |
| Income Tax | N/A | 44 | -5 | 48 | 4 |
| Net Income Continuous | -1,441 | 9,614 | 248 | -2,268 | -1,643 |
| Net Income | $-1,441 | $9,614 | $248 | $-2,268 | $-1,643 |
| EPS Basic Total Ops | -0.13 | 0.89 | 0.02 | -0.21 | -0.15 |
| EPS Basic Continuous Ops | -0.13 | 0.89 | 0.02 | -0.21 | -0.15 |
| EPS Diluted Total Ops | -0.13 | 0.89 | 0.02 | -0.21 | -0.15 |
| EPS Diluted Continuous Ops | -0.13 | 0.89 | 0.02 | -0.21 | -0.15 |
| EPS Diluted Before Non-Recurring Items | -0.13 | 0.88 | 0.02 | -0.16 | N/A |
| EBITDA(a) | $-971 | $9,581 | $646 | $-1,800 | $-1,249 |